Compass Pathways PLC

5Y6

Company Profile

  • Business description

    Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

  • Contact

    33 Broadwick Street
    LondonW1F 0DQ
    GBR

    E: [email protected]

    https://compasspathways.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2025

    Employees

    166

Stocks News & Analysis

stocks

2 companies poised to capitalize on the rise of GLP-1 drugs

Why Pfizer and Roche look like top choices for investors in the war to tip the scales.
stocks

Does this bank have what it takes to compete with the big 4?

Organic growth and a recent acquisition were the focus of their investor day.
stocks

This ASX share is shrinking to greatness

A defensive opportunity for investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,915.0026.100.29%
CAC 408,108.436.31-0.08%
DAX 4024,046.0117.870.07%
Dow JONES (US)47,739.32215.67-0.45%
FTSE 1009,645.0921.92-0.23%
HKSE25,765.36319.72-1.23%
NASDAQ23,545.9032.22-0.14%
Nikkei 22550,581.9490.070.18%
NZX 50 Index13,508.8422.520.17%
S&P 5006,846.5123.89-0.35%
S&P/ASX 2008,624.4028.800.34%
SSE Composite Index3,924.0821.270.55%

Market Movers